Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CU06-1004 for Diabetic Macular Edema
NCT05573100Phase 2Completed
- Sponsor
- Curacle Co., Ltd.
- Start
- Dec 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of CU06-RE in diabetic macular edema (DME), sponsored by Curacle Co., Ltd.. Started Dec 2022; status: completed.
02
Drugs
CU06-RE
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05573100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05573100.